107 related articles for article (PubMed ID: 31065277)
1. Induced Pluripotent Stem Cell Derivation and Ex Vivo Gene Correction Using a Mucopolysaccharidosis Type 1 Disease Mouse Model.
Miki T; Vazquez L; Yanuaria L; Lopez O; Garcia IM; Ohashi K; Rodriguez NS
Stem Cells Int; 2019; 2019():6978303. PubMed ID: 31065277
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts.
de Carvalho TG; Schuh R; Pasqualim G; Pellenz FM; Filippi-Chiela EC; Giugliani R; Baldo G; Matte U
Gene; 2018 Dec; 678():33-37. PubMed ID: 30081189
[TBL] [Abstract][Full Text] [Related]
3. In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.
Schuh RS; Poletto É; Pasqualim G; Tavares AMV; Meyer FS; Gonzalez EA; Giugliani R; Matte U; Teixeira HF; Baldo G
J Control Release; 2018 Oct; 288():23-33. PubMed ID: 30170069
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
5. Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers.
Schuh RS; de Carvalho TG; Giugliani R; Matte U; Baldo G; Teixeira HF
Eur J Pharm Biopharm; 2018 Jan; 122():158-166. PubMed ID: 29122734
[TBL] [Abstract][Full Text] [Related]
6. Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I.
Suga M; Kondo T; Imamura K; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Enami T; Furujo M; Saijo K; Nakamura Y; Osawa M; Saito MK; Yamanaka S; Inoue H
Stem Cell Res; 2019 Apr; 36():101406. PubMed ID: 30849633
[TBL] [Abstract][Full Text] [Related]
7. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
8. Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.
Lito S; Burda P; Baumgartner M; Sloan-Béna F; Táncos Z; Kobolák J; Dinnyés A; Krause KH; Marteyn A
Stem Cell Res; 2019 Dec; 41():101604. PubMed ID: 31678774
[TBL] [Abstract][Full Text] [Related]
9. Patient iPSC-derived neural stem cells exhibit phenotypes in concordance with the clinical severity of mucopolysaccharidosis I.
Swaroop M; Brooks MJ; Gieser L; Swaroop A; Zheng W
Hum Mol Genet; 2018 Oct; 27(20):3612-3626. PubMed ID: 30052969
[TBL] [Abstract][Full Text] [Related]
10. Targeting a Pre-existing Anti-transgene T Cell Response for Effective Gene Therapy of MPS-I in the Mouse Model of the Disease.
Squeri G; Passerini L; Ferro F; Laudisa C; Tomasoni D; Deodato F; Donati MA; Gasperini S; Aiuti A; Bernardo ME; Gentner B; Naldini L; Annoni A; Biffi A; Gregori S
Mol Ther; 2019 Jul; 27(7):1215-1227. PubMed ID: 31060789
[TBL] [Abstract][Full Text] [Related]
11. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
[TBL] [Abstract][Full Text] [Related]
13. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
Unger EG; Durrant J; Anson DS; Hopwood JJ
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene.
Hartung SD; Reddy RG; Whitley CB; McIvor RS
Hum Gene Ther; 1999 Sep; 10(13):2163-72. PubMed ID: 10498248
[TBL] [Abstract][Full Text] [Related]
15. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
16. Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human alpha-L-iduronidase gene.
Anson DS; Bielicki J; Hopwood JJ
Hum Gene Ther; 1992 Aug; 3(4):371-9. PubMed ID: 1525210
[TBL] [Abstract][Full Text] [Related]
17. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
Barbosa Mendes A; do Nascimento CC; D'Almeida V
PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
[TBL] [Abstract][Full Text] [Related]
18. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometry.
Oestreich AK; Garcia MR; Yao X; Pfeiffer FM; Nobakhti S; Shefelbine SJ; Wang Y; Brodeur AC; Phillips CL
Mol Genet Metab Rep; 2015 Dec; 5():3-11. PubMed ID: 28649535
[TBL] [Abstract][Full Text] [Related]
20. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs.
Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM
Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
